Fundamental changes in healthcare such as new regulations, falling reimbursement rates and the growing number of purchasing associations are making it increasingly difficult for medical technology companies to remain on a path of growth and profitability in a conventional manner. At the same time, new topics such as value-based care, personalized medicine, digitization and the associated consumerization offer unprecedented opportunities.
In order to adequately meet these challenges, medical technology companies must understand the mechanisms of their market as well as individual customer requirements holistically. In a dynamic market environment, strategies, solutions and organizational structures must be consistently evaluated and aligned with the needs of patients, service providers and payers. Previously untapped potentials in market development must be identified in order to act more successfully.
Homburg & Partner supports medical technology and diagnostic consumer and capital goods suppliers on a global level with dedicated teams specialized in the industry. We advise listed and medium-sized companies as well as start-ups. We have many years of experience and excellent expertise in medical technology, especially in the following key areas:
Homburg & Partner has been advising providers of in-vitro (e.g. high-throughput equipment, point-of-care testing or patient self-testing) and in-vivo diagnostics (e.g. CRT, MRI or X-ray equipment) solutions for diagnosing the state of health of patients for more than ten years.
Whether endoscopes, surgical devices or respiration technologies – nationally and internationally active manufacturers of medical devices profit from their cooperation with Homburg & Partner through exclusive market insights.
Manufacturers of components with lower technical characteristics such as consumables for outpatient and hospital care have trusted Homburg & Partner for decades.